JIN MEDICAL INTERNATIONAL LTD.’s New Ultralight Electric Wheelchairs and Electric Mobility Vehicles Win Top Industrial Design Awards in China
16 Junho 2023 - 9:00AM
JIN MEDICAL INTERNATIONAL LTD. (the "Company" or “JinMed”) (NASDAQ:
ZJYL), a Cayman Islands holding company with Chinese operating
entities that manufacture and develop wheelchairs and living aids
products, today announced that the Company’s new ultralight
electric wheelchairs and electric mobility vehicles designed for
the elderly and developed in collaboration with Nanjing Tech
University ("NJTech"), have both received the top awards at the 9th
Zijin Award for Industrial Design Competition for their exceptional
designs and engineering functionalities.
The Zijin Award for Industrial Design
Competition is a prestigious award in the field of industrial
design in China, and is organized by the China Industrial Design
Association. The award recognizes the outstanding contributions of
companies and designers in product design, industrial design, brand
design, packaging design, and exhibition design, etc.
The judging panel evaluates the designs based on
several criteria, including innovativeness, aesthetic appeal,
practicality, and sustainability, while also considering their
market applications.
The Company’s award-winning electric wheelchairs
and electric mobility vehicles are expected to be ready for sale to
the mass market this year.
Mr. Erqi Wang, Chairman and CEO of the Company
stated, "Winning the awards is a significant achievement, and we
are honored to have our products recognized by the Zijin Award for
Industrial Design Competition, which represents excellence in the
field of industrial design. ”
“At JinMed we strive to design products that are
both functional and aesthetically pleasing, and these awards
validate our efforts. We will endeavor to continue to push the
boundaries of innovation and design to create products that improve
the quality of life for individuals with limited mobility."
About Jin Medical International
Ltd.
Founded in 2006 and headquartered at Changzhou
City, Jiangsu Province of China, the Company, through its Chinese
operating entities, designs and manufactures wheelchairs and living
aids products for people with disabilities, the elderly, and people
recovering from injuries. The Company’s Chinese operating entities
operate 2 manufacturing plants with approximately 228,257 square
feet in the aggregate in Changzhou City and Taizhou City, Jiangsu
Province, China. The Company’s Chinese operating entities have
established relationships with over 40 distributors in China, and
over 20 in the other regions of the world where it currently sells
the products. The majority of the Company’s wheelchair products,
with more than 30 models, are sold to dealers in Japan and China,
including Nissin Medical Industries Co., Ltd, one of the largest
medical device distributors in Japan. The Company’s Chinese
operating entities own 106 patents and are in the process of
registering 22 additional patents with the Patent Administration
Department of the People’s Republic of China and continuously
deliver innovative wheelchair designs that are both lightweight and
ergonomic each year. For more information, please
visit: http://www.zhjmedical.com.
Forward-Looking
Statement
This press release contains forward-looking
statements as defined by the Private Securities Litigation Reform
Act of 1995. Forward-looking statements include statements
concerning plans, objectives, goals, strategies, future events or
performances, and underlying assumptions and other statements that
are other than statements of historical facts. When the Company
uses words such as "may," "will," "intend," "should," "believe,"
"expect," "anticipate," "project," "estimate" or similar
expressions that do not relate solely to historical matters, it is
making forward-looking statements. Forward-looking statements are
not guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks, including, but not limited to, the
following: the Company's ability to achieve its goals and
strategies, the Company's future business development and plans for
future business development, including its financial conditions and
results of operations, product and service demand and acceptance,
reputation and brand, the impact of competition and pricing,
changes in technology, government regulations, fluctuations in
general economic and business conditions, and assumptions
underlying or related to any of the foregoing and other risks
contained in reports filed by the Company with the U.S. Securities
and Exchange Commission ("SEC"). For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, as
well as its current reports on Form 6-K and other filings, all of
which are available for review at www.sec.gov. The Company
undertakes no obligation to publicly revise these forward-looking
statements to reflect events or circumstances that arise after the
date hereof.
For more information, please contact:Investor
RelationsWealth Financial Services LLCJanice
WangEmail: services@wealthfsllc.comPhone: +86 13811768599+1
628 283 9214
Jin Medical (NASDAQ:ZJYL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Jin Medical (NASDAQ:ZJYL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024